Why MS Patients Need More Antibiotics: Key Findings

Credibility

Interest

Key Takeaway

People with multiple sclerosis (MS) use antibiotics much more often than those without MS, which shows they face more infections.

What They Found

In a study of people with MS in the Netherlands, it was found that about 38% used at least one antibiotic between 2018 and 2020. This is much higher than the general population, indicating that MS patients may get infections more easily. Women and older people with MS were more likely to use antibiotics, and those taking many medications also had higher usage. During lockdowns, antibiotic use actually dropped, possibly because fewer people were visiting doctors or getting infections. Nitrofurantoin was the most common antibiotic prescribed, which is usually used for bladder infections.

Who Should Care and Why

This study is important for MS patients and their caregivers because it highlights how infections can be a bigger problem for them. Just like how a car might need more oil changes if it’s used more often, MS patients might need more antibiotics due to their health condition. Caregivers can be more aware of the need to monitor for signs of infections in their loved ones. Healthcare providers can use this information to better manage and prevent infections in MS patients. Overall, understanding this can help improve daily health care for those living with MS.

Important Considerations

The study only looked at patients in the Netherlands, so the findings might be different in other countries. Also, it didn’t explore why MS patients get more infections, which is an important question. Lastly, the data was collected during a specific time, so it may not reflect current trends after the pandemic.

Categories:

Living with MS Mental Wellness Nutrition

Article Topics:

Netherlandsantibioticsdrug utilization studyinfectionsmultiple sclerosisnitrofurantoinurinary tract infection

Whether you’ve recently been diagnosed with Multiple Sclerosis (MS) or are seeking to broaden your understanding of this complex, neurodegenerative disease, navigating the latest research can feel overwhelming. Studies published in respected medical journals like Pharmacoepidemiology and drug safety often range from early-stage, exploratory work to advanced clinical trials. These evidence-based findings help shape new disease-modifying therapies, guide symptom management techniques, and deepen our knowledge of MS progression.

However, not all research is created equal. Some clinical research studies may have smaller sample sizes, evolving methodologies, or limitations that warrant careful interpretation. For a more comprehensive, accurate understanding, we recommend reviewing the original source material—accessible via the More Details section above—and consulting with healthcare professionals who specialize in MS care.

By presenting a wide range of MS-focused studies—spanning cutting-edge treatments, emerging therapies, and established best practices—we aim to empower patients, caregivers, and clinicians to stay informed and make well-informed decisions when managing Multiple Sclerosis.

Back to News